±è¿ø ¸íÀÇ

½ÉÇ÷°ü ÁßÀç½Ã¼úÀÇ Çõ½ÅÀ» À̲ô´Â ¸®´õ

±è¿ø ¸íÀÇ

  • ¼Ò ¼Ó
    °æÈñ´ëÇб³º´¿ø
  • Áø·á°ú
    ½ÉÀå³»°ú
  • Àü¹®ºÐ¾ß
    ÇãÇ÷¼º ½ÉÁúȯ, ¸»ÃÊÇ÷°üÁúȯ, µ¿¸Æ°æÈ­, °íÇ÷¾Ð

ÇãÇ÷¼º ½ÉÀåÁúȯ°ú ¸»ÃÊÇ÷°ü Áúȯ ºÐ¾ßÀÇ Àü¹®°¡·Î ¼Õ²ÅÈ÷´Â ±è¿ø ±³¼ö´Â ÃֽŠÁßÀç½Ã¼ú ±â¹ýÀ» µµÀÔÇÏ¿© ȯÀÚµéÀÇ Ä¡·á ¼º°ú¸¦ ³ôÀ̰í ÀÖ´Ù. ´ÙÇÐÁ¦Àû Á¢±ÙÀ» ÅëÇØ º¹ÀâÇÑ ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Ä¡·á Àü·«À» ¼ö¸³Çϸç, Áö¼ÓÀûÀÎ ¿¬±¸¸¦ ÅëÇØ »õ·Î¿î Ä¡·á¹ý °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ´Ù. ±¹³»¿Ü Çмú Ȱµ¿À» ÅëÇØ ½ÉÇ÷°ü ÀÇÇÐ ¹ßÀüÀ» ¼±µµÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • Àü³²´ë ÀÇ´ë Çлç
  • Àü³²´ë ÀÇ´ë ¼®»ç
  • Àü³²´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³º´¿ø ½ÉÀå³»°ú ±³¼ö

ÇÐȸȰµ¿

Academic activities
  • ¹Ì±¹ ½ÉÀ庴ÇÐȸ Á¤È¸¿ø
  • ´ëÇÑ ÁßÀç½Ã¼ú¿¬±¸È¸ ÀÎÁõÁ¦À§¿ø
  • ´ëÇÑ ½ºÅÙÆ®¿¬±¸ÇÐȸ È«º¸ÀÌ»ç
  • ´ëÇÑ Ç÷ÀüÁöÇ÷ÇÐȸ ÀÌ»ç
  • ´ëÇÑ °íÇ÷¾ÐÇÐȸ / À¯·´ ½ÉÀåÇÐȸ / ±¹Á¦ ³»Ç÷°üÇÐȸ Á¤È¸¿ø
Ç÷°ü³»ÇÇ ±â´ÉÀÇ Æò°¡-¼øÈ¯±âÁúȯ °ü¸®¿¡ Ȱ¿ëÇÒ Æò°¡¿Í ½ÇÁ¦
´ëÇ¥¼­Àû

Ç÷°ü³»ÇÇ ±â´ÉÀÇ Æò°¡-¼øÈ¯±âÁúȯ °ü¸®¿¡ Ȱ¿ëÇÒ Æò°¡¿Í ½ÇÁ¦

  • ÀúÀÚ(±Û)±è¿ø ¿Ü
  • ÃâÆÇ»ç´ëÇÑÀÇÇÐ
  • ¹ßÇàÀÏ2017³â 11¿ù 17ÀÏ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 2°Ç
Á¦ ¸ñ ¼øÈ¯±â ÀÓ»ó Ã߸®ÀÇ ºñ¹ý
ÃâÆÇ»ç ¹ßÇàÀÏ 2014³â 07¿ù
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö
Á¦ ¸ñ Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö
Á¦ ¸ñ Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI)
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö
Á¦ ¸ñ 2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö
Á¦ ¸ñ BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagy
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö
Á¦ ¸ñ Long-Term Clinical Effects of Carotid Intraplaque Neovascularization in Patients with Coronary Artery Disease
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö
Á¦ ¸ñ Troponin Aptamer on an Atomically Flat Au Nanoplate Platform for Detection of Cardiac Troponin I
¹ßÇ¥³âµµ 2020³â ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°æÈñ´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-958-8114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °­Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°­À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.

°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä